Clinical Trials Browser

Phase 3 × Carcinoma, Basal Cell × Fluorouracil × Clear all

NCT06150144 2024-01-02

The Efficacy and Safety of Using Intralesional 5-fluorouracil for Basal Cell Carcinoma

Phase 3 Unknown

Carcinoma, Basal Cell